{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-059063","form_type":"8-K","ticker":"SYBX","cik":"0001527599","company_name":"SYNLOGIC, INC.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.843034+00:00","generated_at":"2026-06-02T00:46:44.980686+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Synlogic posts Q1 net loss of $31.6M; retains advisor to explore strategic alternatives","bullets":["Retained Lucid Capital Markets to evaluate acquisition, merger, or other strategic transaction.","Cash and short-term securities of $32.3M as of March 31, 2024.","Net loss of $31.6M ($2.60 per share) versus $15.6M ($3.39) in Q1 2023.","Restructuring charge of $28.2M related to discontinuation of Phase 3 PKU study of SYNB1934.","R&D expenses fell to $7.7M from $12.5M; G&A to $2.9M from $4.0M year-over-year."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-059063","json":"https://secwatch.observer/filing/0000950170-24-059063.json","markdown":"https://secwatch.observer/filing/0000950170-24-059063.md","text":"https://secwatch.observer/filing/0000950170-24-059063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527599/000095017024059063/0000950170-24-059063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527599/000095017024059063/sybx-20240514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:46:44.980686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"481e9950eed3a2b5cd278c4af07390d929df82e6","claim":"SYNLOGIC, INC. reported the quarter ended March 31, 2024 results: revenue $0.01 million, net income consolidated net loss of $31.6 million, or $2.60 per share, EPS $2.60 per share.","evidence_excerpt":"transaction. First Quarter 2024 Financial Results As of March 31, 2024 Synlogic had cash, cash equivalents, and short-term marketable securities of $32.3 million. Revenue was $0.01 million for the three months ended March 31, 2024, compared to $0.2 million for the corresponding period in 2023. Revenue for the three months ended March 31, 2024 was related to a","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527599/000095017024059063/0000950170-24-059063-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$0.01 million"},{"label":"Net income","value":"consolidated net loss of $31.6 million, or $2.60 per share"},{"label":"EPS","value":"$2.60 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}